Evidence map›Paper›PMID 33463956›Full record

ArticleCritical reviews in immunology2020

How a Proposed Hypothesis during My PhD Training Shaped My Career.

Scheherazade Sadegh-Nasseri

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Critical reviews in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Scheherazade Sadegh-NasseriDepartment of Pathology, Johns Hopkins University, Baltimore, MD, USA.

Funding

Role of DM in Generation of Immunodominant Epitope(s)R01AI063764 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SADEGH-NASSERI, SCHEHERAZADE · 2006 to 2015
$3.6M
Unconventional Sources of Peptides for Antigen PresentationR01AI121174 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI SADEGH-NASSERI, SCHEHERAZADE · 2017 to 2022
$2.7M
STRUCTURE/BIOLOGY OF SHORT LIVED MHC II LIGAND COMPLEXESR01GM053549 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI SADEGH-NASSERI, SCHEHERAZADE · 1998 to 2007
$1.9M
Understanding the Impacts of HLA-DO in vivoR01AI120634 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SADEGH-NASSERI, SCHEHERAZADE · 2016 to 2019
$1.6M
Molecular Mechanisms of HLA-DO in Antigen ProcessingR21AI101987 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SADEGH-NASSERI, SCHEHERAZADE · 2012 to 2013
$433k
Cell Free System for Identification of MHC Class II Immunodominant EpitopesR56AI091923 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SADEGH-NASSERI, SCHEHERAZADE · 2011 to 2011
$328k
Role of DM in generation in immunodominant epitope(s)R56AI063764 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SADEGH-NASSERI, SCHEHERAZADE · 2005 to 2005
$325k
NIAID NIH HHS R01 AI063764NIAID NIH HHS R01 AI120634NIAID NIH HHS R01 AI121174NIAID NIH HHS R21 AI101987NIAID NIH HHS R56 AI063764NIAID NIH HHS R56 AI091923NIGMS NIH HHS R01 GM053549
6 · The paper itself

Abstract

In this memoir-style essay, I have narrated the evolution of my scientific career, as deeply influenced by my PhD training and the mentorship of Professor Eli Sercarz. Starting in his lab, and continuing to my own laboratory, many of the questions we have pursued link in some way to Eli's ideas. In this essay, I have summarized the path that I followed after graduating from his lab and highlight findings along the way. I apologize to my colleagues whose work was not discussed here due to the nature of this review and space limitations.

Identifiers

PMID33463956
PMCPMC11014643

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.